Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorSobczak, Amelie Isabelle Sylvie
dc.contributor.authorPitt, Samantha J.
dc.contributor.authorSmith, Terry K
dc.contributor.authorAjjan, Ramzi A.
dc.contributor.authorStewart, Alan J.
dc.date.accessioned2020-10-09T15:30:16Z
dc.date.available2020-10-09T15:30:16Z
dc.date.issued2021-01
dc.identifier270305140
dc.identifier6c163be1-71ee-48ff-8e2d-8fbacc478344
dc.identifier85092304864
dc.identifier000592664200012
dc.identifier.citationSobczak , A I S , Pitt , S J , Smith , T K , Ajjan , R A & Stewart , A J 2021 , ' Lipidomic profiling of plasma free fatty acids in type-1 diabetes highlights specific changes in lipid metabolism ' , Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids , vol. 1866 , no. 1 , 158823 . https://doi.org/10.1016/j.bbalip.2020.158823en
dc.identifier.issn1388-1981
dc.identifier.otherORCID: /0000-0003-4580-1840/work/81797587
dc.identifier.otherORCID: /0000-0003-2257-1595/work/81797623
dc.identifier.urihttps://hdl.handle.net/10023/20755
dc.descriptionThis research was funded by the British Heart Foundation [grant numbers PG/15/9/31270, FS/15/42/3155].en
dc.description.abstractType-1 diabetes mellitus (T1DM) is associated with metabolic changes leading to alterations in glucose and lipid handling. While T1DM- associated effects on many major plasma lipids have been characterised, such effects on plasma free fatty acids (FFA) have not been fully examined. Using gas chromatography-mass spectrometry, we measured the plasma concentrations of FFA species in individuals with T1DM (n=44) and age/sex-matched healthy controls (n=44). Relationships between FFA species and various parameters were evaluated. Plasma concentrations of myristate (14:0), palmitoleate (16:1), palmitate (16:0), linoleate (18:2), oleate (18:1c9), cis-vaccenate (18:1c11), eicosapentaenoate (20:5), arachidonate (20:4) and docosahexanoate (22:6) were reduced in the T1DM group (p<0.0001 for all, except p=0.0020 for eicosapentaenoate and p=0.0068 for arachidonate); α-linolenate (18:3) and dihomo-γ- linolenate (20:3) concentrations were unchanged. Saturated/unsaturated FFA ratio, n-3/n-6 ratio, de novo lipogenesis index (palmitate (main lipogenesis product)/linoleate (only found in diet)) and elongase index (oleate/palmitoleate) were increased in the T1DM group (p=0.0166, p=0.0089, p<0.0001 and p=0.0008 respectively). The stearoyl-CoA desaturase 1 (SCD1) index 1 (palmitoleate/palmitate) and index 2 (oleate/stearate) were reduced in T1DM (p<0.0001 for all). The delta-(5)- desaturase (D5D) index (arachidonate/dihomo-γ-linolenate) was unchanged. Age and sex had no effect on plasma FFA concentrations in T1DM, while SCD1 index 1 was positively correlated (p=0.098) and elongase index negatively correlated with age (p=0.0363). HbA1c was negatively correlated with all plasma FFAs concentrations measured except α- linolenate and dihomo-γ-linolenate. Correlations were observed between plasma FFAs and cholesterol and HDL, but not LDL or diabetes duration. Collectively, these results aid our understanding of T1DM and its effects on lipid metabolism.
dc.format.extent9
dc.format.extent6447666
dc.language.isoeng
dc.relation.ispartofBiochimica et Biophysica Acta - Molecular and Cell Biology of Lipidsen
dc.subjectFatty acid metabolismen
dc.subjectGC-MSen
dc.subjectHbA1cen
dc.subjectLipid metabolismen
dc.subjectLipidomicsen
dc.subjectNon-esterified fatty aciden
dc.subjectQH301 Biologyen
dc.subjectRC Internal medicineen
dc.subjectNDASen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subject.lccQH301en
dc.subject.lccRCen
dc.titleLipidomic profiling of plasma free fatty acids in type-1 diabetes highlights specific changes in lipid metabolismen
dc.typeJournal articleen
dc.contributor.sponsorBritish Heart Foundationen
dc.contributor.sponsorBritish Heart Foundationen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.contributor.institutionUniversity of St Andrews. Sir James Mackenzie Institute for Early Diagnosisen
dc.contributor.institutionUniversity of St Andrews. Institute of Behavioural and Neural Sciencesen
dc.contributor.institutionUniversity of St Andrews. Biomedical Sciences Research Complexen
dc.contributor.institutionUniversity of St Andrews. Cellular Medicine Divisionen
dc.identifier.doi10.1016/j.bbalip.2020.158823
dc.description.statusPeer revieweden
dc.identifier.grantnumberPG/15/9/31270en
dc.identifier.grantnumberFS/15/42/31556en


This item appears in the following Collection(s)

Show simple item record